Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

11 Results

Guidelines and Advice

Docetaxel plus Cyclophosphamide as Adjuvant Therapy for Early, Operable Breast Cancer

Status: Archived
ID: CED 9

Aug 2008

Guidelines and Advice

Fulvestrant for Systemic Therapy of Locally Advanced or Metastatic Breast Cancer in Postmenopausal Women: Guideline Recommendations

Status: Archived
ID: 1-13

Sep 2008

Guidelines and Advice

Safe Administration of Systemic Cancer Therapy Part 2: Administration of Systemic Treatment and Management of Preventable Adverse Events

Status: In-Review
ID: 12-12-2
Version: 2

Nov 2018

Guidelines and Advice

Management of Stage I Nonseminomatous Testicular Cancer

Status: Archived
ID: 3-19

Feb 2008

Guidelines and Advice

Treatment of Acute Myeloid Leukemia in Older Patients

Status: Archived
ID: 6-14

Dec 2008

Guidelines and Advice

Systemic therapy for the treatment of adult patients with lower-risk myelodysplastic syndromes

Status: In-Review
ID: 6-13

Mar 2018

Guidelines and Advice

Recommendations for the Delivery of Psychosocial Oncology Services in Ontario

Status: Current

Apr 2018

Guidelines and Advice

The Role of Primary Tumour Location in the Selection of Biologics for the Treatment of Unresectable Metastatic Colorectal Cancer: An Endorsement of a Canadian Consensus Statement

Status: Current
ID: GL END 2-31

Jul 2018

Guidelines and Advice

Safety Considerations for the Implementation of Subcutaneous Rituximab Formulation

Status: Current
Version: 1

Jun 2018

Guidelines and Advice

Cancer Care Ontario Beyond-Use Date Recommendations Report

Status: Current
ID: N/A
Version: 1

Mar 2018

Guidelines and Advice

Endorsement of the 2018 American Society of Clinical Oncology Treatment of Malignant Pleural Mesothelioma Guideline

Status: In-Review
ID: 7-14
Version: 3

Dec 2018